XT
HBIO icon

XTX Topco’s Harvard Bioscience HBIO Stock Holding History

XTX Topco’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,935
Closed -$26.3K – 4038
2025
Q4 		$26.3K Buy
+3,935
New +$23.3K ﹤0.01% 3001
2025
Q3 		– Sell
-1,113
Closed -$4.94K – 2833
2025
Q2 		$4.94K Buy
+1,113
New +$4.65K ﹤0.01% 2257
2023
Q4 		– Sell
-1,332
Closed -$57.3K – 1790
2023
Q3 		$57.3K Sell
1,332
-174
-12% -$8.03K 0.01% 1260
2023
Q2 		$82.7K Buy
+1,506
New +$82.6K 0.01% 1183
2022
Q3 		– Sell
-3,280
Closed -$118K – 1211
2022
Q2 		$118K Buy
+3,280
New +$148K 0.05% 608

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's HBIO Position: Q1 2026 in Review

XTX Topco sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 3,935 shares — an estimated $26.3K sold.

XTX Topco first reported a position in HBIO in Q2 2022 and held it in 5 quarters. The position peaked at $118K in Q2 2022. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • XTX Topco reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 3,935 Harvard Bioscience shares in Q1 2026, an estimated $26.3K.
  • XTX Topco first reported a position in Harvard Bioscience in Q2 2022 and held it in 5 quarters.
  • XTX Topco's Harvard Bioscience position peaked at $118K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.